Rituximab in the treatment of diffuse large B-cell lymphomas
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference30 articles.
1. Overview of the clinical development of rituximab: First monoclonal antibody approved for the treatment of lymphoma;Grillo-López;Semin Oncol,1999
2. Anti-B4-blocked ricin: A phase II trial of 7 day continuous infusion in patients with multiple myeloma;Grossbard;Br J Haematol,1998
3. Iodine-131–anti-B1 radioimmunotherapy for B-cell lymphoma;Kaminski;J Clin Oncol,1996
4. Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20+ B-cell non-Hodgkin's lymphoma;Witzig;J Clin Oncol,1999
5. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma;Maloney;Blood,1994
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biophysical Approach to Understand Life and Cancer;Aging and Cancer;2024-09-11
2. Monoclonal Antibody and Targeted Toxin Therapy;Holland‐Frei Cancer Medicine;2022-10-21
3. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review;Critical Reviews in Oncology/Hematology;2021-09
4. Efficacy and safety of second‑generation CAR T‑cell therapy in diffuse large B‑cell lymphoma: A meta‑analysis;Molecular and Clinical Oncology;2020-07-29
5. mRNA expression profile analysis reveals a C‑MYC/miR‑34a pathway involved in the apoptosis of diffuse large B‑cell lymphoma cells induced by Yiqichutan treatment;Experimental and Therapeutic Medicine;2020-06-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3